Mutations in SPATA13/ASEF2 cause primary angle closure glaucoma


Autoři: Naushin H. Waseem aff001;  Sancy Low aff002;  Amna Z. Shah aff003;  Deepa Avisetti aff005;  Pia Ostergaard aff006;  Michael Simpson aff007;  Katarzyna A. Niemiec aff005;  Belen Martin-Martin aff008;  Hebah Aldehlawi aff005;  Saima Usman aff005;  Pak Sang Lee aff001;  Anthony P. Khawaja aff001;  Jonathan B. Ruddle aff009;  Ameet Shah aff010;  Ege Sackey aff006;  Alexander Day aff002;  Yuzhen Jiang aff002;  Geoff Swinfield aff011;  Ananth Viswanathan aff001;  Giovanna Alfano aff003;  Christina Chakarova aff003;  Heather J. Cordell aff012;  David F. Garway-Heath aff001;  Peng T. Khaw aff001;  Shomi S. Bhattacharya aff001;  Ahmad Waseem aff005;  Paul J. Foster aff001
Působiště autorů: NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom aff001;  Moorfields Eye Hospital NHS Foundation Trust, City Road, London, United Kingdom aff002;  UCL Institute of Ophthalmology, Bath Street, London, United Kingdom aff003;  Department of Ophthalmology, St. Thomas’ Hospital, Westminster Bridge Road, London, United Kingdom aff004;  Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Queen Mary University of London, London, United Kingdom aff005;  Medical Genetics Unit, St. George’s University of London, Cranmer Terrace, London, United Kingdom aff006;  Genetics and Molecular Medicine, King’s College London, Great Maze Pond, London, United Kingdom aff007;  Blizard Advanced Light Microscopy, Blizard Institute, Queen Mary University of London, London, United Kingdom aff008;  Department of Ophthalmology, University of Melbourne, Victoria, Australia aff009;  Department of Ophthalmology, Royal Free Hospital NHS Foundation Trust, Pond Street, London, United Kingdom aff010;  Society of Genealogists, Goswell Road, London, United Kingdom aff011;  Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom aff012
Vyšlo v časopise: Mutations in SPATA13/ASEF2 cause primary angle closure glaucoma. PLoS Genet 16(4): e32767. doi:10.1371/journal.pgen.1008721
Kategorie: Research Article
doi: 10.1371/journal.pgen.1008721

Souhrn

Current estimates suggest 50% of glaucoma blindness worldwide is caused by primary angle-closure glaucoma (PACG) but the causative gene is not known. We used genetic linkage and whole genome sequencing to identify Spermatogenesis Associated Protein 13, SPATA13 (NM_001166271; NP_001159743, SPATA13 isoform I), also known as ASEF2 (Adenomatous polyposis coli-stimulated guanine nucleotide exchange factor 2), as the causal gene for PACG in a large seven-generation white British family showing variable expression and incomplete penetrance. The 9 bp deletion, c.1432_1440del; p.478_480del was present in all affected individuals with angle-closure disease. We show ubiquitous expression of this transcript in cell lines derived from human tissues and in iris, retina, retinal pigment and ciliary epithelia, cornea and lens. We also identified eight additional mutations in SPATA13 in a cohort of 189 unrelated PACS/PAC/PACG samples. This gene encodes a 1277 residue protein which localises to the nucleus with partial co-localisation with nuclear speckles. In cells undergoing mitosis SPATA13 isoform I becomes part of the kinetochore complex co-localising with two kinetochore markers, polo like kinase 1 (PLK-1) and centrosome-associated protein E (CENP-E). The 9 bp deletion reported in this study increases the RAC1-dependent guanine nucleotide exchange factors (GEF) activity. The increase in GEF activity was also observed in three other variants identified in this study. Taken together, our data suggest that SPATA13 is involved in the regulation of mitosis and the mutations dysregulate GEF activity affecting homeostasis in tissues where it is highly expressed, influencing PACG pathogenesis.

Klíčová slova:

Cornea – Epithelium – Eyes – Glaucoma – Immunohistochemistry techniques – Mutation – Nuclear staining – Guanine nucleotide exchange factors


Zdroje

1. Quigley HA. Angle-closure glaucoma-simpler answers to complex mechanisms: LXVI Edward Jackson Memorial Lecture. Am J Ophthalmol. 2009;148(5):657–69 e1. Epub 2009/11/03. doi: 10.1016/j.ajo.2009.08.009 19878757.

2. Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–42. Epub 2002/01/30. doi: 10.1136/bjo.86.2.238 11815354; PMCID: PMC1771026.

3. Weinreb RN, Khaw PT. Primary open-angle glaucoma. The Lancet. 2004;363(9422):1711–20. doi: 10.1016/s0140-6736(04)16257-0

4. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7. Epub 2006/02/21. doi: 10.1136/bjo.2005.081224 16488940; PMCID: PMC1856963.

5. Alsbirk PH. Anterior chamber depth, genes and environment. A population study among long-term Greenland Eskimo immigrants in Copenhagen. Acta Ophthalmol (Copenh). 1982;60(2):223–4. Epub 1982/04/01. doi: 10.1111/j.1755-3768.1982.tb08376.x 7136533.

6. Aung T, Bowman R, Chew PT, Seah SK, Ang LP, Yap E, et al. Genome-wide linkage scan for primary angle closure glaucoma. Investgative Ophthalmology & Visual Science. 2003;44:3224.

7. Vithana EN, Khor CC, Cornes BK, Nongpiur ME, Jonas JB, Saw SM, et al., editors. Association Analysis Identifies a Susceptibility Locus on Chromosome 3q27 for Primary Angle Closure Glaucoma. Investigative Ophthalmology & Visual Science; 2012. ARVO Annual Meeting Abstract.

8. Vithana EN, Khor CC, Qiao C, Nongpiur ME, George R, Chen LJ, et al. Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma. Nat Genet. 2012;44(10):1142–6. Epub 2012/08/28. doi: 10.1038/ng.2390 22922875; PMCID: PMC4333205.

9. Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, et al. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nat Genet. 2016;48(5):556–62. Epub 2016/04/12. doi: 10.1038/ng.3540 27064256.

10. Chen Y, Chen X, Wang L, Hughes G, Qian S, Sun X. Extended association study of PLEKHA7 and COL11A1 with primary angle closure glaucoma in a Han Chinese population. Invest Ophthalmol Vis Sci. 2014;55(6):3797–802. Epub 2014/05/24. doi: 10.1167/iovs.14-14370 24854855.

11. Awadalla MS, Thapa SS, Hewitt AW, Burdon KP, Craig JE. Association of genetic variants with primary angle closure glaucoma in two different populations. PLoS One. 2013;8(6):e67903. Epub 2013/07/11. doi: 10.1371/journal.pone.0067903 23840785; PMCID: PMC3695871.

12. Lee MC, Chan AS, Goh SR, Hilmy MH, Nongpiur ME, Hong W, et al. Expression of the primary angle closure glaucoma (PACG) susceptibility gene PLEKHA7 in endothelial and epithelial cell junctions in the eye. Invest Ophthalmol Vis Sci. 2014;55(6):3833–41. Epub 2014/05/08. doi: 10.1167/iovs.14-14145 24801512.

13. Lee MC, Shei W, Chan AS, Chua BT, Goh SR, Chong YF, et al. Primary angle closure glaucoma (PACG) susceptibility gene PLEKHA7 encodes a novel Rac1/Cdc42 GAP that modulates cell migration and blood-aqueous barrier function. Hum Mol Genet. 2017;26(20):4011–27. Epub 2017/10/11. doi: 10.1093/hmg/ddx292 29016860.

14. Awadalla MS, Thapa SS, Burdon KP, Hewitt AW, Craig JE. The association of hepatocyte growth factor (HGF) gene with primary angle closure glaucoma in the Nepalese population. Mol Vis. 2011;17:2248–54. Epub 2011/09/08. 21897747; PMCID: PMC3164689.

15. Ayub H, Khan MI, Micheal S, Akhtar F, Ajmal M, Shafique S, et al. Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts. Mol Vis. 2010;16:18–25. Epub 2010/01/14. 20069064; PMCID: PMC2805420.

16. Wang IJ, Lin S, Chiang TH, Chen ZTY, Lin LLK, Hung PT, et al. The association of membrane frizzled-related protein (MFRP) gene with acute angle-closure glaucoma–a pilot study. Mol Vis. 2008;14:1673–9. PMCID: PMC2532703. 18781223

17. Chen X, Chen Y, Wiggs JL, Pasquale LR, Sun X, Fan BJ. Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma. PLoS One. 2016;11(6):e0157093. Epub 2016/06/09. doi: 10.1371/journal.pone.0157093 27272641; PMCID: PMC4896618.

18. Kawasaki Y, Sagara M, Shibata Y, Shirouzu M, Yokoyama S, Akiyama T. Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42. Oncogene. 2007;26(55):7620–27. Epub 2007/06/30. doi: 10.1038/sj.onc.1210574 17599059.

19. Bristow JM, Sellers MH, Majumdar D, Anderson B, Hu L, Webb DJ. The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration. J Cell Sci. 2009;122(Pt 24):4535–46. Epub 2009/11/26. doi: 10.1242/jcs.053728 19934221; PMCID: PMC2787464.

20. Jean L, Majumdar D, Shi M, Hinkle LE, Diggins NL, Ao M, et al. Activation of Rac by Asef2 promotes myosin II-dependent contractility to inhibit cell migration on type I collagen. J Cell Sci. 2013;126(Pt 24):5585–97. Epub 2013/10/23. doi: 10.1242/jcs.131060 24144700; PMCID: PMC3860307.

21. Evans JC, Hines KM, Forsythe JG, Erdogan B, Shi M, Hill S, et al. Phosphorylation of serine 106 in Asef2 regulates cell migration and adhesion turnover. J Proteome Res. 2014;13(7):3303–13. Epub 2014/05/31. doi: 10.1021/pr5001384 24874604; PMCID: PMC4084842.

22. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One. 2009;4(3):e4849. Epub 2009/03/17. doi: 10.1371/journal.pone.0004849 19287496; PMCID: PMC2654098.

23. Sagara M, Kawasaki Y, Iemura SI, Natsume T, Takai Y, Akiyama T. Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration. Oncogene. 2009;28(10):1357–65. Epub 2009/01/20. doi: 10.1038/onc.2008.478 19151759.

24. Nguyen Ba AN, Pogoutse A, Provart N, Moses AM. NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction. BMC Bioinformatics. 2009;10:202. Epub 2009/07/01. doi: 10.1186/1471-2105-10-202 19563654; PMCID: PMC2711084.

25. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J. 2004;86(6):3993–4003. Epub 2004/06/11. doi: 10.1529/biophysj.103.038422 15189895; PMCID: PMC1304300.

26. Hamann MJ, Lubking CM, Luchini DN, Billadeau DD. Asef2 functions as a Cdc42 exchange factor and is stimulated by the release of an autoinhibitory module from a concealed C-terminal activation element. Mol Cell Biol. 2007;27(4):1380–93. Epub 2006/12/06. doi: 10.1128/MCB.01608-06 17145773; PMCID: PMC1800726.

27. Harripaul R, Vasli N, Mikhailov A, Rafiq MA, Mittal K, Windpassinger C, et al. Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Mol Psychiatry. 2018;23(4):973–84. Epub 2017/04/12. doi: 10.1038/mp.2017.60 28397838.

28. Edwards AC, Aliev F, Bierut LJ, Bucholz KK, Edenberg H, Hesselbrock V, et al. Genome-wide association study of comorbid depressive syndrome and alcohol dependence. Psychiatr Genet. 2012;22(1):31–41. Epub 2011/11/09. doi: 10.1097/YPG.0b013e32834acd07 22064162; PMCID: PMC3241912.

29. Boraska V, Franklin CS, Floyd JA, Thornton LM, Huckins LM, Southam L, et al. A genome-wide association study of anorexia nervosa. Mol Psychiatry. 2014;19(10):1085–94. Epub 2014/02/12. doi: 10.1038/mp.2013.187 24514567; PMCID: PMC4325090.

30. Bourbia N, Chandler P, Codner G, Banks G, Nolan PM. The guanine nucleotide exchange factor, Spata13, influences social behaviour and nocturnal activity. Mamm Genome. 2019;30(3–4):54–62. Epub 2019/04/26. doi: 10.1007/s00335-019-09800-9 31020388.

31. Figlioli G, Kohler A, Chen B, Elisei R, Romei C, Cipollini M, et al. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. J Clin Endocrinol Metab. 2014;99(10):E2084–92. Epub 2014/07/17. doi: 10.1210/jc.2014-1734 25029422.

32. Scott CM, Wong EM, Joo JE, Dugue PA, Jung CH, O'Callaghan N, et al. Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry. Exp Mol Pathol. 2018;105(3):404–10. Epub 2018/11/14. doi: 10.1016/j.yexmp.2018.11.006 30423315; PMCID: PMC6289279.

33. Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, et al. A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell. 2001;8(2):375–81. Epub 2001/09/08. doi: 10.1016/s1097-2765(01)00305-7 11545739.

34. Kawasaki Y, Tsuji S, Muroya K, Furukawa S, Shibata Y, Okuno M, et al. The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice. EMBO Rep. 2009;10(12):1355–62. Epub 2009/11/07. doi: 10.1038/embor.2009.233 19893577; PMCID: PMC2799213.

35. Kawasaki Y, Jigami T, Furukawa S, Sagara M, Echizen K, Shibata Y, et al. The adenomatous polyposis coli-associated guanine nucleotide exchange factor Asef is involved in angiogenesis. J Biol Chem. 2010;285(2):1199–207. Epub 2009/11/10. doi: 10.1074/jbc.M109.040691 19897489; PMCID: PMC2801248.

36. Kawasaki Y, Tsuji S, Sagara M, Echizen K, Shibata Y, Akiyama T. Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase. J Biol Chem. 2009;284(33):22436–43. Epub 2009/06/16. doi: 10.1074/jbc.M109.020768 19525225; PMCID: PMC2755965.

37. Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, Gan L, et al. Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function. Mol Cell Biol. 2001;21(22):7707–13. Epub 2001/10/18. doi: 10.1128/MCB.21.22.7707-7713.2001 11604506; PMCID: PMC99941.

38. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275(5300):668–70. Epub 1997/01/31. doi: 10.1126/science.275.5300.668 9005853.

39. DeGeer J, Lamarche-Vane N. Rho GTPases in neurodegeneration diseases. Exp Cell Res. 2013;319(15):2384–94. Epub 2013/07/09. doi: 10.1016/j.yexcr.2013.06.016 23830879.

40. Inoue T, Tanihara H. Rho-associated kinase inhibitors: a novel glaucoma therapy. Prog Retin Eye Res. 2013;37:1–12. Epub 2013/06/19. doi: 10.1016/j.preteyeres.2013.05.002 23770081.

41. Epstein DL, Rowlette LL, Roberts BC. Acto-myosin drug effects and aqueous outflow function. Invest Ophthalmol Vis Sci. 1999;40(1):74–81. Epub 1999/01/15. 9888429.

42. Del Debbio CB, Santos MF, Yan CY, Ahmad I, Hamassaki DE. Rho GTPases control ciliary epithelium cells proliferation and progenitor profile induction in vivo. Invest Ophthalmol Vis Sci. 2014;55(4):2631–41. Epub 2014/04/03. doi: 10.1167/iovs.13-13162 24692128.

43. Toriyama M, Mizuno N, Fukami T, Iguchi T, Toriyama M, Tago K, et al. Phosphorylation of doublecortin by protein kinase A orchestrates microtubule and actin dynamics to promote neuronal progenitor cell migration. J Biol Chem. 2012;287(16):12691–702. Epub 2012/03/01. doi: 10.1074/jbc.M111.316307 22367209; PMCID: PMC3339951.

44. Jean L, Yang L, Majumdar D, Gao Y, Shi M, Brewer BM, et al. The Rho family GEF Asef2 regulates cell migration in three dimensional (3D) collagen matrices through myosin II. Cell Adh Migr. 2014;8(5):460–7. Epub 2014/12/18. doi: 10.4161/19336918.2014.983778 25517435; PMCID: PMC4594452.

45. Friedman DS, Gazzard G, Foster P, Devereux J, Broman A, Quigley H, et al. Ultrasonographic biomicroscopy, Scheimpflug photography, and novel provocative tests in contralateral eyes of Chinese patients initially seen with acute angle closure. Arch Ophthalmol. 2003;121(5):633–42. Epub 2003/05/14. doi: 10.1001/archopht.121.5.633 12742840.

46. Kawakami M, Liu X, Dmitrovsky E. New Cell Cycle Inhibitors Target Aneuploidy in Cancer Therapy. Annu Rev Pharmacol Toxicol. 2019;59:361–77. Epub 2018/08/16. doi: 10.1146/annurev-pharmtox-010818-021649 30110577.

47. Jiang H, Deng R, Yang X, Shang J, Lu S, Zhao Y, et al. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat Chem Biol. 2017;13(9):994–1001. Epub 2017/08/02. doi: 10.1038/nchembio.2442 28759015.

48. Silberstein M, Weissbrod O, Otten L, Tzemach A, Anisenia A, Shtark O, et al. A system for exact and approximate genetic linkage analysis of SNP data in large pedigrees. Bioinformatics. 2013;29(2):197–205. Epub 2012/11/20. doi: 10.1093/bioinformatics/bts658 23162081; PMCID: PMC3546794.

49. Sambrook JF, Russell DW. Molecular Cloning: A Laboratory Manual, 3rd ed.: Cold Spring Harbor Laboratory Press; 2001.

50. Aldehlawi H, Niemiec KA, Avisetti DR, Lalli A, Teh MT, Waseem A. The monoclonal antibody EPR1614Y against the stem cell biomarker keratin K15 lacks specificity and reacts with other keratins. Sci Rep. 2019;9(1):1943. Epub 2019/02/15. doi: 10.1038/s41598-018-38163-5 30760780; PMCID: PMC6374370.

51. Bose A, Teh MT, Hutchison IL, Wan H, Leigh IM, Waseem A. Two mechanisms regulate keratin K15 expression in keratinocytes: role of PKC/AP-1 and FOXM1 mediated signalling. PLoS One. 2012;7(6):e38599. Epub 2012/07/05. doi: 10.1371/journal.pone.0038599 22761689; PMCID: PMC3384677.

52. Waseem A, Ali M, Odell EW, Fortune F, Teh MT. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol. 2010;46(7):536–42. Epub 2010/04/20. doi: 10.1016/j.oraloncology.2010.03.022 20400365.

53. Vishal M, Sharma A, Kaurani L, Alfano G, Mookherjee S, Narta K, et al. Genetic association and stress mediated down-regulation in trabecular meshwork implicates MPP7 as a novel candidate gene in primary open angle glaucoma. BMC Med Genomics. 2016;9:15. Epub 2016/03/24. doi: 10.1186/s12920-016-0177-6 27001270; PMCID: PMC4802647.

54. Zhang Y. I-TASSER: fully automated protein structure prediction in CASP8. Proteins. 2009;77 Suppl 9:100–13. Epub 2009/09/22. doi: 10.1002/prot.22588 19768687; PMCID: PMC2782770.

55. Plessner M, Melak M, Chinchilla P, Baarlink C, Grosse R. Nuclear F-actin formation and reorganization upon cell spreading. J Biol Chem. 2015;290(18):11209–16. Epub 2015/03/12. doi: 10.1074/jbc.M114.627166 25759381; PMCID: PMC4416828.


Článek vyšel v časopise

PLOS Genetics


2020 Číslo 4

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Nová éra v léčbě migrény
nový kurz
Autoři: MUDr. Eva Medová, MUDr. Tomáš Nežádal, Ph.D.

Význam nutraceutik u kardiovaskulárních onemocnění
Autoři:

Pneumowebinář
Autoři:

White paper - jak vidíme optimální péči o zubní náhrady
Autoři: MUDr. Jindřich Charvát, CSc.

Faktory ovlivňující léčbu levotyroxinem

Všechny kurzy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se